Strategic Initiative

Slingshot members are tracking this corporate initiative:

Alpine Immune Sciences (ALPN) and Horizon Therapeutics (HZNP) Announce Exclusive License and Collaboration Agreement to Develop Novel Protein-Based Therapies for Autoimmune and Inflammatory Diseases

Source Link:
https://ir.alpineimmunesciences.com/news-releases/news-release-details/alpine-immune-sciences-and-horizon-therapeutics-plc-announce

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
HZNP
100%
ALPN
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Dec 16, 2021
Projected Implementation:
Q4, 2021
Relevance Tracked Until:
Q1, 2022
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Autoimmune Diseases, Inflammatory Disorders
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.